> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Seeks Collaborators for Anti-Virus Invention
- URL: https://www.fdaweb.com/fda-seeks-collaborators-for-anti-virus-invention/
- Published: 2016-02-12T12:00:00.000Z
- Updated: 2026-09-15T02:35:42.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134756

*Federal Register* Notice: The invention listed in this document: Therapeutic and prophylactic anti-Influenza virus neuraminidase 1 (N1) antibody (CD6) with a novel epitope that spans neuramindase dimers, is owned by an agency of the U.S. government and is available for licensing in accordance with federal regulations to achieve expeditious commercialization of results of federally funded research and development. The neuramindase 1 (N1) subtype of NA is important because it is found in the two pandemic H1N1 influenza virus strains (1918 Spanish flu and 2009 swine flu) and the H5N1 avian influenza virus. Anti-neuramindase antibody CD6 is a novel antibody that spans a conserved 30 amino acid epitope across the lateral face of a neuramindase (NA) dimer. FDA is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize this technology. The subject technology may offer an alternative to therapeutic NA Inhibitors. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-02-12/pdf/2016-02887.pdf?ref=fdaweb.com)